KERSTIN STEPHENS: Open Payments
NPI 1952362048 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 11 payments from 7 companies in 2025. Trend: 2023 $473 · 2024 $635 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 4 | $344 |
| Corcept Therapeutics | 1 | $189 |
| AstraZeneca Pharmaceuticals LP | 2 | $126 |
| ABBVIE INC. | 1 | $126 |
| GENZYME CORPORATION | 1 | $120 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $93 |
| CSL Behring | 1 | $35 |
Products named: Dexcom G6 Transmitter, Korlym, AVYCAZ, FABRAZYME, Andembry, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
